Actor
Biocon SA
Primarily engaged in the business of development and commercialization of generic recombinant human insulin and its analogues for global markets under various developing other novel molecules into commercial products or licensable assets internal as well as partnered programs.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.06 Generic & Biosimilar
1.10 Small Molecules
Business model
1. Entreprise
1.5 Multinational
Organization Type
Public Company
Visit website
Domains
Endocrine & Metabolic
Main sector
Biotech
Contact
Rue de l'Avenir 2
2800 Délémont / JU
+41 (32) 4232152